Matthew P. Pando
Directeur Général chez Recognify Life Sciences, Inc.
Profil
Matthew P.
Pando is the founder of Recognify Life Sciences, Inc. He is currently the Chief Executive & Financial Officer at Boost Neuroscience, Inc. He was previously the Member-Management Board & EVP-Therapeutics at Exonhit from 2008 to 2012 and the Chief Scientific Officer & VP-Research at Eurobio-Scientific SA. Pando holds a doctorate from The Salk Institute for Biological Studies and the University of California San Diego, and an undergraduate degree from Colorado State University.
Postes actifs de Matthew P. Pando
| Sociétés | Poste | Début |
|---|---|---|
Recognify Life Sciences, Inc.
 Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Directeur Général | - |
Boost Neuroscience, Inc.
 Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Directeur Général | - |
Anciens postes connus de Matthew P. Pando
| Sociétés | Poste | Fin |
|---|---|---|
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Directeur Technique/Scientifique/R&D | 20/12/2012 |
| EUROBIO SCIENTIFIC | Directeur Technique/Scientifique/R&D | - |
Formation de Matthew P. Pando
| The Salk Institute for Biological Studies | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EUROBIO SCIENTIFIC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Recognify Life Sciences, Inc.
Recognify Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Recognify Life Sciences, Inc. develops treatments for cognitive impairment associated with schizophrenia. The company is based in Brisbane, CA. The company was founded by Thomas C. Südhof, Matthew P. Pando, Kristen Angela MacFarlane, Gary Walker. Matthew P. Pando has been the CEO since incorporation. | Commercial Services |
Boost Neuroscience, Inc.
Boost Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Boost Neuroscience, Inc. is an American company that focuses on researching and developing therapies for age-related cognitive deficits. The CEO of the company is Matthew P. Pando. | Commercial Services |
